{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-076568","form_type":"8-K","ticker":"QURE","cik":"0001590560","company_name":"uniQure N.V.","filed_at":"2024-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.672425+00:00","generated_at":"2026-06-01T00:01:10.031016+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"uniQure sells Lexington manufacturing facility to Genezen for $25M, reduces cash burn $40M/year","bullets":["Consideration $25M: $12.5M of Series C preferred stock and $12.5M convertible note (8%, 63-month maturity).","Genezen to manufacture HEMGENIX commercial supply; CEO Matt Kapusta joins Genezen board after close.","Company expects to reduce annual cash burn by ~$40M and repay $50M debt, saving interest expense.","Majority of Lexington employees offered jobs at Genezen; transaction expected to close early Q3 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-076568","json":"https://secwatch.observer/filing/0001104659-24-076568.json","markdown":"https://secwatch.observer/filing/0001104659-24-076568.md","text":"https://secwatch.observer/filing/0001104659-24-076568.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590560/000110465924076568/0001104659-24-076568-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590560/000110465924076568/tm2418608d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T00:01:10.031016+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}